Cyclosporine (CsA) in combination with steroids is rapidly emerging as the immunosuppression of choice in kidney transplantation, particularly in high-risk populations for immunologic graft loss like presensitized patients, HLA nonidentical living related donor recipients and unrelated living donor (ULD) recipients. The experience on 94 consecutive kidney transplants from living donors in the CsA age, initiated at the University of Rome in November 1982, is here reported.
Long-term results in recipients of mismatched related and unrelated living kidneys in the cyclosporine age
Caricato M.;
1988-01-01
Abstract
Cyclosporine (CsA) in combination with steroids is rapidly emerging as the immunosuppression of choice in kidney transplantation, particularly in high-risk populations for immunologic graft loss like presensitized patients, HLA nonidentical living related donor recipients and unrelated living donor (ULD) recipients. The experience on 94 consecutive kidney transplants from living donors in the CsA age, initiated at the University of Rome in November 1982, is here reported.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
